Company / Capital Expenditures
ORAGENICS INC Capital Expenditures History
FY2013-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$127.5K
FY2023
5-year range
$43.9K / $127.5K
FY2019-FY2023
Trend
+190.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $43,876 to $127,519 over the past 2 years.
Based on SEC 10-K filings.
$127,519 in FY2023 with a 10-year CAGR of +27.7%.
Improved from $43,876 to $127,519 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- +27.7%
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2023, capital expenditures increased 190.6% year-over-year.
- Lowest capital expenditures in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $127.5K | +190.6% |
| FY2022 | $43.9K | +0.0% |
| FY2021 | $43.9K | -64.8% |
| FY2018 | $124.7K | +358.9% |
| FY2017 | $27.2K | -73.5% |
| FY2016 | $102.5K | -7.4% |
| FY2015 | $110.7K | +0.0% |
| FY2014 | $110.7K | +897.5% |
| FY2013 | $11.1K | +0.0% |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026